Eating ultra-processed food is associated with increased risk for type 2 diabetes, according to a new study from French researchers. Ultra-processed foods are often high in calories and low in nutrients. Previous studies have found a diet high in these foods to be associated with health problems including heart disease, obesity and certain cancers. Read […]
According to recent research, greater than 75% of hospitals in the United States follow outdated insulin management protocols that are no longer recommended by the American Diabetes Association, American Association of Clinical Endocrinologists, and Society of Hospital Medicine. Read more
Breast milk is deemed to be the “best” for baby, but a recent study suggests there may be additional benefits for mothers and their long-term health in the form of improved cardiovascular health and reduced risk of type 2 diabetes. Read more
Intermittent fasting, which is also known as time-restricted eating (TRE), could help people with metabolic syndrome prevent their condition from progressing to type 2 diabetes, according to a recent study. Study participants were instructed to continue eating their regular diet but to fit all meals within a 10-hour window, while fasting for the other 14 […]
A new trial has found that premature babies may be more likely to develop diabetes at some point in their life than other babies. The researchers found that babies born before 37 weeks are 21% more likely to develop type 1 diabetes and 26% more likely to develop type 2 diabetes within the study time […]
Children who have had an episode of acute pancreatitis may have an increased risk for developing type 2 diabetes before the age of 40, researchers say. Read more
Serious influenza complications can result in a higher risk of hospitalization, and also mortality, in patients with diabetes. The influenza virus, commonly known as the flu, has the potential of exacerbating chronic health problems that lead to worsening the disease state of diabetes. Read more
Researchers may be only beginning to understand how Alzheimer’s disease and type 2 diabetes could be linked. Deciphering the connection could lead to earlier Alzheimer’s diagnosis and better treatments for both diseases. The connection involves how the brain metabolizes blood sugar and the factors that influence that process, including diet, sleep, and cardiovascular health. […]
Oral semaglutide, brand name Rybelsus, is the first GLP-1 agonist that can be taken by mouth rather than requiring an injection. Studies have shown a significant reduction in A1c, a reduction in cardiovascular disease, and a reduction in weight, without the risk of hypoglycemia, for this drug. Patients must carefully follow instructions for taking the […]
The FDA has approved a new treatment of Invokana for diabetic chronic kidney disease (CKD), which affects one in three patients with type 2 diabetes. CKD increases the risk for serious cardiovascular events and end-stage renal disease in patiens with type 2 diabetes. The approval of Invokana meets a 20 year need for therapy to […]
Metabolic syndrome (MetS) is a set of interconnected biochemical, clinical, and metabolic factors that increase risk of heart disease and type 2 diabetes. Characteristics of MetS include high blood pressure, high blood glucose, and excess body fat around the waist. Carbohydrate intake stimulates insulin secretion, which in turn stimulates fat storage, is linked to MetS. […]
Many people who drink lots of sugary beverages typically switch to diet sodas when diagnosed with type 2 diabetes, because they have no sugar and are supposed to be “healthier.” However, new evidence is showing that diet soda may actually contribute to a person’s diabetes. Read more
Double diabetes or double disease (DD) refers to having type 1 diabetes (T1D) along with insulin resistance, a characteristic of type 2 diabetes (T2D). Clear criteria to define this group of patients is not very well established. Read more
Losing as little as 10% of body weight within the first few years following a type 2 diabetes diagnosis can actually send the condition into remission — that is, a decrease or even disappearance of symptoms, allowing people to cease taking medication — according to a new study. Read more
In addition to glycemic control, liraglutide also promotes weight loss, which can be helpful in patients with obesity and type 2 diabetes. However, development of gallstones may be a common side effect in patients that are on liraglutide for the treatment of their type 2 diabetes. Read more
Thyroid hormones are essential for carbohydrate metabolism, thus, thyroid dysfunctions can influence the development of type 2 diabetes. A large, nation-wide study investigated the effects of thyroid disorders on the occurrence of type 2 diabetes. Read more
The U.S. Food and Drug Administration (FDA) has approved a new medication, Rybelsus (semaglutide) oral tablets, for use in controlling blood sugar in adults with type 2 diabetes, along with diet and exercise. Rybelsus is the first medication in the glucagon-like peptide (GLP-1) receptor class that does not need to be injected to be approved […]
New research says that specialist analysis of the lens in the eye can predict which patients may develop type 2 diabetes or impaired glucose tolerance (IGT) or prediabetes. The study used a newly developed biomicroscope which can detect advanced glycation end-products (AGEs) in the eye via a simple scan. Read more
Taller people are at less risk for type 2 diabetes, according to a new study from Germany. For every 10 centimeters of additional height, there was a 41% reduced risk of type 2 in men and a 33% reduced risk in women, after adjusting to remove the potential effects of age, education, lifestyle, and waist […]
A new study suggests that the number of new cases of type 2 diabetes could be stabilizing, or even falling, in many countries. The analysis looked at 47 studies from the mid-1960s through 2014, from the U.S., Canada, and multiple European countries. One third of the groups studied between 2006 and 2014 saw a reduction […]